BRIGHTGENE
Live / Registered — Registered (as of 31 Aug 2021)
What this means for you
Registered since 31 Aug 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79278137
- Registration number
- 6465606
- Mark type
- Stylized text
- Filed
- 28 Oct 2019
- Published for opposition
- 15 Jun 2021
- Registered
- 31 Aug 2021
- Attorney of record
- Eric Lamb
Goods and services
- Class 005 — Pharmaceuticals: Injectable solutions for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; prepared Chinese medicine for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; chemical pharmaceutical preparations for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; medicinal preparations for the mouth in the form of tablets or compressed tablets for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; medicines for human purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; biochemical medical drug for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; pharmaceutical preparations for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; chemical preparations for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; drugs for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; active pharmaceutical ingredients for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders
Owner
Prosecution history
- 27 Feb 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 07 Feb 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 07 Feb 2022 — FINAL DISPOSITION PROCESSED
- 30 Nov 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 31 Aug 2021 — REGISTERED-PRINCIPAL REGISTER
- 24 Jul 2021 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 07 Jul 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 07 Jul 2021 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 15 Jun 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Jun 2021 — PUBLISHED FOR OPPOSITION
- 13 Jun 2021 — NOTIFICATION PROCESSED BY IB
- 26 May 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 26 May 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 26 May 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 May 2021 — ASSIGNED TO LIE